Defective MHC class II expression in an MHC class II deficiency patient iscaused by a novel deletion of a splice donor site in the MHC class II transactivator gene
A. Peijnenburg et al., Defective MHC class II expression in an MHC class II deficiency patient iscaused by a novel deletion of a splice donor site in the MHC class II transactivator gene, IMMUNOGENET, 51(1), 2000, pp. 42-49
MHC class II deficiency patients are mutated for transcription factors that
regulate the expression of major histocompatibility complex (MHC) class II
genes. Four complementation groups (A-D) are defined and the gene defectiv
e in group A has been shown to encode the MHC class II transactivator (CIIT
A). Here, we report the molecular characterization of a new MHC class II de
ficiency patient, ATU, Cell fusion experiments indicated that ATU belongs t
o complementation group A. Subsequent mutation analysis revealed that the C
IITA mRNA lacked 84 nucleotides, This deletion was the result of the absenc
e of a splice donor site in the CIITA gene of ATU. As a result of this nove
l homozygous genomic deletion, ATU CIITA failed to transactivate MHC class
II genes. Furthermore, this truncated CIITA of ATU did not display a domina
nt negative effect on CIITA-mediated transactivation of various isotypic MH
C class II promoters.